Maxim Group initiated coverage on VSee Lab with a new price target
$VSEE
Medical/Nursing Services
Health Care
Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/24/2025 | $5.00 | Buy | Maxim Group |
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
Company Accomplishments, Initiatives and Strong AI Powered Product Pipeline Setting a Path to Record Success in 2025 VSee Health (NASDAQ:VSEE), a rapidly growing leader in AI-powered telehealth, is redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by more than 1,000 clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health accelerates telehealth adoption by enabling seamless, scalable and secure digital health solutions across hospitals, governments, and enterprise organizations. Today, VSee Health has issued the following letter to shareholders from Co-C
VSee Health, Inc. (NASDAQ:VSEE), a leader in customizable digital health platforms and telehealth workflow solutions, announces securing a contract totalling $444K with one of the largest counties in the U.S., to deploy a white-label telehealth and data analytics platform for mental and behavioral health services. This strategic win highlights VSee's growing government sector presence and its ability to deliver scalable healthcare technology to underserved populations. "Our modular platform architecture creates significant competitive advantages in the public sector market," states Dr. Milton Chen, Co-CEO of VSee Health. "Government entities serving vulnerable populations like the homel
VSee Health (NASDAQ:VSEE), a leading provider of telehealth solutions, partnered with LanguageLine Solutions, the world's leading interpretation service to enable instant, one-touch interpreter access across 240+ languages, further strengthening VSee Health's position as a leading telehealth solutions provider for hospitals, enterprises, and government healthcare systems. With the global digital health market projected to exceed $787 billion, this move enhances VSee's competitive edge and is expected to drive increased platform adoption while unlocking new revenue streams through improved accessibility and workflow automation. "At VSee, our mission is to make healthcare accessible to ev
ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth
ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so
8-K - VSEE HEALTH, INC. (0001864531) (Filer)
8-K - VSEE HEALTH, INC. (0001864531) (Filer)
8-K - VSEE HEALTH, INC. (0001864531) (Filer)
SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)
SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)
SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)
Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00